One case of allergic shock caused by tocilizumab injection

doi:10.19803/j.1672-8629.20230594

Abstract

Abstract: Objective To analyze the characteristics of anaphylactic shock induced by tocilizumab injection in order to provide reference for clinical safe and rational drug use. Methods One case of anaphylactic shock caused by tocilizumab was analyzed. The related literature was reviewed while the causes, prevention and treatment of such adverse drug reactions were analyzed. Results According to the clinical manifestations of the patient and the correlation between the drug and the time of administration, this case of anaphylactic shock was considered to have been caused by tocilizumab. The symptoms of anaphylactic shock were relieved after effective anti-allergic treatment. Conclusion Clinicians should be wary of anaphylactic shock and other allergic conditions related to the use of tocilizumab, which should not be used in allergic patients.

Key words: tocilizumab, injection, allergic shock, adverse drug reaction, children

CLC Number:

CHEN Jie, ZHANG Bin, ZHAO Jun, ZHANG Chuanzhou. One case of allergic shock caused by tocilizumab injection[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 349-351.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20230594

https://www.zgywjj.com/EN/Y2024/V21/I3/349

References

[1] MARTINI A, LOVELL DJ, ALBANI S, et al.Juvenile idiopathic arthritis[J]. Nat Rev Dis Primers, 2022, 8(1): 5.
[2] LI CF, SHI XW.Treatment strategies of juvenile idiopathic arthritis in biologics era[J]. Chinese Journal of New Drugs(中国新药杂志), 2022, 31(23): 2318-2322.
[3] CHOY EH, DE BF, TAKEUCHI T, et al.Translating IL-6 biology into effective treatments[J]. Nat Rev Rheumatol, 2020, 16(6): 335-345.
[4] LIU YT, ZENG LW, WANG NN.Study on the effect of tocilizumab combined with celecoxib on inflammatory response in patients with moderate to severe rheumatoid arthritis[J]. Journal of China Prescription Drug(中国处方药), 2023, 21(7): 103-106.
[5] LI YB, LIU J, HU J, et al.Application of biological agents in the treatment of systemic juvenile idiopathic arthritis[J]. Chinese Journal of Practical Pediatrics(中国实用儿科杂志), 2017, 32(4): 308-313.
[6] BONNY M, BUYSE V, SUYS E.Rapidly progressive malignant melanoma in a patient treated with tocilizumab[J]. J Am Acad Dermatol, 2012, 67(2): e78-e79.
[7] Roche Pharma (Schweiz) Ltd. Tocilizumab Injection Package Insert, JS20170010[EB/OL]. (2017-09-25)[2023-03-15]. https://db.yaozh.com/instruct/65541956.html.
[8] SHU B, JIANG W, SHEN AZ.Literature analysis of adverse drug reactions induced by tocilizumab[J]. Chinese Journal of New Drugs(中国新药杂志), 2021, 30(4): 369-376.
[9] CANSEVER M, ŞAHIN N, DURSUN I, et al.Successful slow desensitization to tocilizumab in a 15-year-old patient[J]. J Investig Allergol Clin Immunol, 2018, 28(6): 436-438.
[10] SOYER O, DEMIR S, BILGINER Y, et al.Severe hypersensitivity reactions to biological drugs in children with rheumatic diseases[J]. Pediatr Allergy Immunol, 2019, 30(8): 833-840.
[11] PARK EH, LEE EY, SHIN K, et al.Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review[J]. Rheumatol Int, 2020, 40(5): 791-798.
[12] Genentech. ACTEMRA^®(TOCILIZUMAB)[EB/OL].(2019-06-01)[2020-03-08]. https://www.gene.com/download/pdf/actemra_prescribing.pdf.
[13] MoH, NMPA. Adverse Drug Reaction Reporting and Monitoring Management Measures[EB/OL]. (2004-03-04)[2020-03-01]. http://www.nhc.gov.cn/wjw/bmgz/200804/8fd34a2690c04eeeb266856bf364931e.shtml.
[14] LI W, YANG T, WANG C.Current status and progress of prevention and treatment of chronic obstructive pulmonary disease in China[J]. Journal of Chinese Research Hospitals(中国研究型医院), 2020, 7(5): 78-84.
[15] LI M, SUN H, ZHANG JS.Update in the clinical research of drug-induced anaphylactic shock[J]. Journal of Practical Shock(实用休克杂志), 2021, 5(1): 1-5.
[16] XIANG L, WAN WL, QU ZH, et al.Recommedations for the diagnosis and treatment of anaphylaxis in Chinese children[J]. Chinese Journal of Applied Clinical Pediatrics(中华实用儿科临床杂志), 2021, 36(6): 410-416.
[17] Information Product. Tocilizumab[EB/OL].(2019-09-19)[2023-03-08]. https://www.drugs.com/cdi/tocilizumab-intravenous.html.
[18] JUSTET A, NEUKIRCH C, POUBEAU P, et al.Successful rapid tocilizumab desensitization in a patient with still disease[J]. J Allergy Clin Immunol Pract, 2014, 2(5): 631-632.